299 related articles for article (PubMed ID: 15477723)
1. Chemotherapy for gastro-enteropancreatic endocrine tumours.
O'Toole D; Hentic O; Corcos O; Ruszniewski P
Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
[TBL] [Abstract][Full Text] [Related]
2. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours.
O'Toole D; Ruszniewski P
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):585-94. PubMed ID: 16183529
[TBL] [Abstract][Full Text] [Related]
3. Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
Ruszniewski P; O'Toole D
Neuroendocrinology; 2004; 80 Suppl 1():74-8. PubMed ID: 15477722
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
Toumpanakis C; Meyer T; Caplin ME
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):131-44. PubMed ID: 17382269
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.
Nikou GC; Marinou K; Thomakos P; Papageorgiou D; Sanzanidis V; Nikolaou P; Kosmidis C; Moulakakis A; Mallas E
Pancreatology; 2008; 8(4-5):510-9. PubMed ID: 18765956
[TBL] [Abstract][Full Text] [Related]
6. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
[TBL] [Abstract][Full Text] [Related]
7. [Treatment strategy of neuroendocrine tumors].
Ducreux M; Baudin E; Schlumberger M
Rev Prat; 2002 Feb; 52(3):290-6. PubMed ID: 11925720
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of pancreatic-duodenal endocrine tumors].
O'Toole D; Kianmanesh R; Farges O; Ruszniewski P
Rev Prat; 2002 Sep; 52(14):1546-53. PubMed ID: 12412302
[TBL] [Abstract][Full Text] [Related]
9. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours.
Plöckinger U; Wiedenmann B
Neuroendocrinology; 2004; 80 Suppl 1():35-8. PubMed ID: 15477715
[TBL] [Abstract][Full Text] [Related]
11. Endocrine tumors of the gastrointestinal tract: systemic treatment.
Oberg K
Anticancer Drugs; 1994 Oct; 5(5):503-19. PubMed ID: 7858282
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Auernhammer CJ; Göke B
Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
[TBL] [Abstract][Full Text] [Related]
13. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
14. [Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy].
Bodelier AG; Haak HR
Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1868-72. PubMed ID: 16970007
[TBL] [Abstract][Full Text] [Related]
15. Ablative therapies for liver metastases of digestive endocrine tumours.
O'Toole D; Maire F; Ruszniewski P
Endocr Relat Cancer; 2003 Dec; 10(4):463-8. PubMed ID: 14713259
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours.
Khan MS; Caplin ME
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S53-74. PubMed ID: 22005115
[TBL] [Abstract][Full Text] [Related]
17. Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France.
Lombard-Bohas C; Mitry E; O'Toole D; Louvet C; Pillon D; Cadiot G; Borson-Chazot F; Aparicio T; Ducreux M; Lecomte T; Etienne PL; Cacheux W; Legoux JL; Seitz JF; Ruszniewski P; Chayvialle JA; Rougier P;
Neuroendocrinology; 2009; 89(2):217-22. PubMed ID: 18719344
[TBL] [Abstract][Full Text] [Related]
18. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
19. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
20. Endocrine tumours of the gastrointestinal tract: Chemotherapy.
Arnold R; Rinke A; Schmidt Ch; Hofbauer L
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):649-56. PubMed ID: 16183533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]